Tirbanibulin (actinic keratosis (Olsen grade 1))

Subject:

• Active Substance: Tirbanibulin
• Name: Klisyri^®
• Therapeutic area: Actinic keratosis
• Pharmaceutical company: Almirall Hermal GmbH

Time table:

• Start: 01.09.2021
• Final decision by G-BA: 17.02.2022

Final decision:

• No additional benefit proved